There are 2867 resources available
1467P - Optimal neoadjuvant treatment choice for localised renal cell carcinoma
Presenter: Leo Jurascheck
Session: Poster session 17
1468P - IO-synthesise RCC: Real-world outcomes of nivolumab in patients (pts) with previously treated advanced non-clear cell renal cell carcinoma (nccRCC) – A pooled analysis from France and Germany
Presenter: Philippe Barthelemy
Session: Poster session 17
1469P - Efficacy and safety of pembrolizumab/axitinib combination in metastatic renal cell carcinoma (mRCC): A multicentric prospective analysis (ProPAXI study)
Presenter: Annalisa Guida
Session: Poster session 17
1471P - Plasma KIM-1 for preoperative identification and risk stratification of renal cell carcinoma
Presenter: Wenxin Xu
Session: Poster session 17
1472P - Biomarkers of the response in metastatic papillary renal cell carcinoma
Presenter: Manon De Vries-Brilland
Session: Poster session 17
1473P - A prognostic microRNA-based signature for relapse risk prediction and definition of therapeutic targets in patients with high-risk localized clear cell renal cell carcinoma
Presenter: Alvaro Pinto Marin
Session: Poster session 17
1474P - Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study)
Presenter: Clara Iglesias Gómez
Session: Poster session 17
1475P - Association of circulating tumor cells (CTCs) with immune checkpoint inhibitor (ICI) responses in metastatic renal cell carcinoma (mRCC)
Presenter: Tian Zhang
Session: Poster session 17
1476P - Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study
Presenter: Sara Elena Rebuzzi
Session: Poster session 17